Genpharmasec Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve 1. To consider and approve Unaudited Standalone and Consolidated Financial Results of the Company along with the Limited Review Report for the quarter ended 31st December, 2025; 2. To consider any other business Matter with the permission of a Chairman.